Cargando…
Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations
PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497877/ https://www.ncbi.nlm.nih.gov/pubmed/23180963 http://dx.doi.org/10.2147/IJN.S34723 |
_version_ | 1782249769904635904 |
---|---|
author | Bonelli, Patrizia Tuccillo, Franca M Federico, Antonella Napolitano, Maria Borrelli, Antonella Melisi, Daniela Rimoli, Maria G Palaia, Raffaele Arra, Claudio Carinci, Francesco |
author_facet | Bonelli, Patrizia Tuccillo, Franca M Federico, Antonella Napolitano, Maria Borrelli, Antonella Melisi, Daniela Rimoli, Maria G Palaia, Raffaele Arra, Claudio Carinci, Francesco |
author_sort | Bonelli, Patrizia |
collection | PubMed |
description | PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer cell line MKN-45. However, high doses of ibuprofen were required to elicit these antiproliferative effects in vitro. The present research compared the antiproliferative effects of ibuprofen delivered freely and released by poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in MKN-45 cells. METHODS: MKN-45 human gastric adenocarcinoma cells were treated with ibuprofen-loaded PLGA NPs. The proliferation of MKN-45 cells was then assessed by cell counting. The uptake of NPs was imaged by fluorescence microscopy and flow cytometry. The release of ibuprofen from ibuprofen-loaded PLGA NPs in the cells was evaluated by gas chromatography–mass spectrometry. RESULTS: Dramatic inhibition of cellular proliferation was observed in cells treated with ibuprofen-loaded PLGA NPs versus those treated with free ibuprofen at the same concentration. The localization of NPs was cytoplasmic. The initiation of ibuprofen release was rapid, commencing within 2 hours, and then increased slowly over time, reaching a maximum concentration at 24 hours. The inhibition of proliferation was confirmed to be due to the intracellular release of ibuprofen from the NPs. Using PLGA NPs as carriers, ibuprofen exerted an antiproliferative activity at concentrations > 100 times less than free ibuprofen, suggesting greater efficiency and less cellular toxicity. In addition, when carried by PLGA NPs, ibuprofen more quickly induced the expression of transcripts involved in proliferation and invasiveness processes. CONCLUSION: Ibuprofen exerted an antiproliferative effect on MKN-45 cells at low concentrations. This effect was achieved using PLGA NPs as carriers of low doses of ibuprofen. |
format | Online Article Text |
id | pubmed-3497877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-34978772012-11-23 Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations Bonelli, Patrizia Tuccillo, Franca M Federico, Antonella Napolitano, Maria Borrelli, Antonella Melisi, Daniela Rimoli, Maria G Palaia, Raffaele Arra, Claudio Carinci, Francesco Int J Nanomedicine Original Research PURPOSE: Epidemiological, clinical, and laboratory studies have suggested that ibuprofen, a commonly used nonsteroidal anti-inflammatory drug, inhibits the promotion and proliferation of certain tumors. Recently, we demonstrated the antiproliferative effects of ibuprofen on the human gastric cancer cell line MKN-45. However, high doses of ibuprofen were required to elicit these antiproliferative effects in vitro. The present research compared the antiproliferative effects of ibuprofen delivered freely and released by poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) in MKN-45 cells. METHODS: MKN-45 human gastric adenocarcinoma cells were treated with ibuprofen-loaded PLGA NPs. The proliferation of MKN-45 cells was then assessed by cell counting. The uptake of NPs was imaged by fluorescence microscopy and flow cytometry. The release of ibuprofen from ibuprofen-loaded PLGA NPs in the cells was evaluated by gas chromatography–mass spectrometry. RESULTS: Dramatic inhibition of cellular proliferation was observed in cells treated with ibuprofen-loaded PLGA NPs versus those treated with free ibuprofen at the same concentration. The localization of NPs was cytoplasmic. The initiation of ibuprofen release was rapid, commencing within 2 hours, and then increased slowly over time, reaching a maximum concentration at 24 hours. The inhibition of proliferation was confirmed to be due to the intracellular release of ibuprofen from the NPs. Using PLGA NPs as carriers, ibuprofen exerted an antiproliferative activity at concentrations > 100 times less than free ibuprofen, suggesting greater efficiency and less cellular toxicity. In addition, when carried by PLGA NPs, ibuprofen more quickly induced the expression of transcripts involved in proliferation and invasiveness processes. CONCLUSION: Ibuprofen exerted an antiproliferative effect on MKN-45 cells at low concentrations. This effect was achieved using PLGA NPs as carriers of low doses of ibuprofen. Dove Medical Press 2012 2012-11-09 /pmc/articles/PMC3497877/ /pubmed/23180963 http://dx.doi.org/10.2147/IJN.S34723 Text en © 2012 Bonelli et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Bonelli, Patrizia Tuccillo, Franca M Federico, Antonella Napolitano, Maria Borrelli, Antonella Melisi, Daniela Rimoli, Maria G Palaia, Raffaele Arra, Claudio Carinci, Francesco Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title | Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title_full | Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title_fullStr | Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title_full_unstemmed | Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title_short | Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
title_sort | ibuprofen delivered by poly(lactic-co-glycolic acid) (plga) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrations |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3497877/ https://www.ncbi.nlm.nih.gov/pubmed/23180963 http://dx.doi.org/10.2147/IJN.S34723 |
work_keys_str_mv | AT bonellipatrizia ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT tuccillofrancam ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT federicoantonella ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT napolitanomaria ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT borrelliantonella ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT melisidaniela ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT rimolimariag ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT palaiaraffaele ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT arraclaudio ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations AT carincifrancesco ibuprofendeliveredbypolylacticcoglycolicacidplgananoparticlestohumangastriccancercellsexertsantiproliferativeactivityatverylowconcentrations |